GlaxoSmithKline Pharmaceuticals Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 04:34 pm
06-11-2025 | 04:34 pm
GSK Pharma's board approved Q2 & H1 financial results. Consolidated profit for Q2 hit ₹257.49 Cr & H1 ₹462.50 Cr. They're also investing ₹1.74 Cr in a solar power project at Nashik for green energy and cost savings.
No comments yet. Be the first to comment!
All announcements from GlaxoSmithKline Pharmaceuticals Limited
